{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T12:41:39Z","timestamp":1791722499016,"version":"4.3.4"},"reference-count":58,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1100099"],"award-info":[{"award-number":["APP1100099"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1147267"],"award-info":[{"award-number":["APP1147267"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015539","name":"Australian Government","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015539","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1100099"],"award-info":[{"award-number":["APP1100099"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1147267"],"award-info":[{"award-number":["APP1147267"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Australian Government","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.atsjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The epidemiological patterns of incident chronic obstructive pulmonary disease (COPD) and lung adenocarcinoma are changing, with an increasing fraction of disease occurring in patients who are never-smokers or were not exposed to traditional risk factors. However, causative mechanism(s) are obscure. Overactivity of Src family kinases (SFKs) and myeloid cell\u2013dependent inflammatory lung epithelial and endothelial damage are independent candidate mechanisms, but their pathogenic convergence has not been demonstrated. Here we present a novel preclinical model in which an activating mutation in Lyn, a nonreceptor SFK that is expressed in immune cells, epithelium, and endothelium\u2014all strongly implicated in the pathogenesis of COPD\u2014causes spontaneous inflammation, early-onset progressive emphysema, and lung adenocarcinoma. Surprisingly, even though activated macrophages, elastolytic enzymes, and proinflammatory cytokines were prominent, bone marrow chimeras formally demonstrated that myeloid cells were not disease initiators. Rather, lung disease arose from aberrant epithelial cell proliferation and differentiation, microvascular lesions within an activated endothelial microcirculation, and amplified EGFR (epidermal growth factor receptor) expression. In human bioinformatics analyses, LYN expression was increased in patients with COPD and was correlated with increased EGFR expression, a known lung oncogenic pathway, and LYN was linked to COPD. Our study shows that a singular molecular defect causes a spontaneous COPD-like immunopathology and lung adenocarcinoma. Furthermore, we identify Lyn and, by implication, its associated signaling pathways as new therapeutic targets for COPD and cancer. Moreover, our work may inform the development of molecular risk screening and intervention methods for disease susceptibility, progression, and prevention of these increasingly prevalent conditions.<\/jats:p>","DOI":"10.1165\/rcmb.2022-0463oc","type":"journal-article","created":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T09:12:27Z","timestamp":1680599547000},"page":"99-112","update-policy":"https:\/\/doi.org\/10.1164\/crossmarkpolicies","source":"Crossref","is-referenced-by-count":11,"title":["Enhanced Lyn Activity Causes Severe, Progressive Emphysema and Lung Cancer"],"prefix":"10.1093","volume":"69","author":[{"given":"Evelyn","family":"Tsantikos","sequence":"first","affiliation":[{"name":"Leukocyte Signalling Laboratory, Department of Immunology and Pathology, Monash University, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy A.","family":"Gottschalk","sequence":"additional","affiliation":[{"name":"Leukocyte Signalling Laboratory, Department of Immunology and Pathology, Monash University, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elan","family":"L\u2019Estrange-Stranieri","sequence":"additional","affiliation":[{"name":"Leukocyte Signalling Laboratory, Department of Immunology and Pathology, Monash University, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin A.","family":"O\u2019Brien","sequence":"additional","affiliation":[{"name":"Leukocyte Signalling Laboratory, Department of Immunology and Pathology, Monash University, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"April L.","family":"Raftery","sequence":"additional","affiliation":[{"name":"Leukocyte Signalling Laboratory, Department of Immunology and Pathology, Monash University, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshanie C.","family":"Wickramasinghe","sequence":"additional","affiliation":[{"name":"Leukocyte Signalling Laboratory, Department of Immunology and Pathology, Monash University, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan L.","family":"McQualter","sequence":"additional","affiliation":[{"name":"School of Health and Biomedical Science, Royal Melbourne Institute of Technology (RMIT) University, Melbourne, Victoria, Australia; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6580-3398","authenticated-orcid":false,"given":"Gary P.","family":"Anderson","sequence":"additional","affiliation":[{"name":"Lung Health Research Centre, Department of Biochemistry and Pharmacology, University of Melbourne, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3751-6751","authenticated-orcid":false,"given":"Margaret L.","family":"Hibbs","sequence":"additional","affiliation":[{"name":"Leukocyte Signalling Laboratory, Department of Immunology and Pathology, Monash University, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,7,1]]},"reference":[{"key":"2026012204072439600_bib1","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1017\/gheg.2018.1","article-title":"The unmet global burden of COPD","volume":"3","author":"Quaderi","year":"2018","journal-title":"Glob Health Epidemiol Genom"},{"key":"2026012204072439600_bib2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.lungcan.2015.08.017","article-title":"The relationship between COPD and lung cancer","volume":"90","author":"Durham","year":"2015","journal-title":"Lung Cancer"},{"key":"2026012204072439600_bib3","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1136\/thoraxjnl-2015-206938","article-title":"Characteristics of COPD in never-smokers and ever-smokers in the general population: results from the CanCOLD study","volume":"70","author":"Tan","year":"2015","journal-title":"Thorax"},{"key":"2026012204072439600_bib4","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1177\/0141076819843654","article-title":"Lung cancer in never-smokers: a hidden disease","volume":"112","author":"Bhopal","year":"2019","journal-title":"J R Soc Med"},{"key":"2026012204072439600_bib5","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1136\/thoraxjnl-2019-213732","article-title":"Chronic obstructive pulmonary disease and lung cancer incidence in never smokers: a cohort study","volume":"75","author":"Park","year":"2020","journal-title":"Thorax"},{"key":"2026012204072439600_bib6","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/nrc2190","article-title":"Lung cancer in never smokers\u2014a different disease","volume":"7","author":"Sun","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"2026012204072439600_bib7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1478-811X-10-21","article-title":"Functions of the Lyn tyrosine kinase in health and disease","volume":"10","author":"Ingley","year":"2012","journal-title":"Cell Commun Signal"},{"key":"2026012204072439600_bib8","doi-asserted-by":"crossref","first-page":"82876","DOI":"10.18632\/oncotarget.12657","article-title":"LYN expression predicts the response to dasatinib in a subpopulation of lung adenocarcinoma patients","volume":"7","author":"Kim","year":"2016","journal-title":"Oncotarget"},{"key":"2026012204072439600_bib9","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1038\/s41467-018-03751-6","article-title":"Massive mining of publicly available RNA-seq data from human and mouse","volume":"9","author":"Lachmann","year":"2018","journal-title":"Nat Commun"},{"key":"2026012204072439600_bib10","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.3390\/biom11091394","article-title":"The underappreciated role of epithelial mesenchymal transition in chronic obstructive pulmonary disease and its strong link to lung cancer","volume":"11","author":"Mahmood","year":"2021","journal-title":"Biomolecules"},{"key":"2026012204072439600_bib11","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S2213-2600(20)30101-6","article-title":"Chronic obstructive pulmonary disease and related phenotypes: polygenic risk scores in population-based and case-control cohorts","volume":"8","author":"Moll","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2026012204072439600_bib12","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.pupt.2005.06.001","article-title":"Murine models of COPD","volume":"19","author":"Brusselle","year":"2006","journal-title":"Pulm Pharmacol Ther"},{"key":"2026012204072439600_bib13","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1038\/nprot.2009.95","article-title":"Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase","volume":"4","author":"DuPage","year":"2009","journal-title":"Nat Protoc"},{"key":"2026012204072439600_bib14","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ejphar.2015.03.029","article-title":"Preclinical murine models of chronic obstructive pulmonary disease","volume":"759","author":"Vlahos","year":"2015","journal-title":"Eur J Pharmacol"},{"key":"2026012204072439600_bib15","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1084\/jem.20020873","article-title":"Constitutive activation of the SRC family kinase Hck results in spontaneous pulmonary inflammation and an enhanced innate immune response","volume":"196","author":"Ernst","year":"2002","journal-title":"J Exp Med"},{"key":"2026012204072439600_bib16","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/mi.2015.84","article-title":"CD11b immunophenotyping identifies inflammatory profiles in the mouse and human lungs","volume":"9","author":"Duan","year":"2016","journal-title":"Mucosal Immunol"},{"key":"2026012204072439600_bib17","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s00439-006-0253-7","article-title":"Association of Hck genetic polymorphisms with gene expression and COPD","volume":"120","author":"Zhang","year":"2007","journal-title":"Hum Genet"},{"key":"2026012204072439600_bib18","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1378\/chest.07-3020","article-title":"The possible role of hematopoietic cell kinase in the pathophysiology of COPD","volume":"135","author":"Yanagisawa","year":"2009","journal-title":"Chest"},{"key":"2026012204072439600_bib19","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3109\/01902148.2011.632062","article-title":"Hematopoietic cell kinase gene polymorphisms and the risk of chronic obstructive pulmonary disease in a Chinese population","volume":"38","author":"Liu","year":"2012","journal-title":"Exp Lung Res"},{"key":"2026012204072439600_bib20","doi-asserted-by":"crossref","first-page":"15752","DOI":"10.18632\/oncotarget.4199","article-title":"Hematopoietic cell kinase (HCK) as a therapeutic target in immune and cancer cells","volume":"6","author":"Poh","year":"2015","journal-title":"Oncotarget"},{"key":"2026012204072439600_bib21","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1084\/jem.20020515","article-title":"Sustained activation of Lyn tyrosine kinase in vivo leads to autoimmunity","volume":"196","author":"Hibbs","year":"2002","journal-title":"J Exp Med"},{"key":"2026012204072439600_bib22","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S1074-7613(01)00208-4","article-title":"Gain- and loss-of-function Lyn mutant mice define a critical inhibitory role for Lyn in the myeloid lineage","volume":"15","author":"Harder","year":"2001","journal-title":"Immunity"},{"key":"2026012204072439600_bib23","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1172\/JCI98224","article-title":"Granulocyte-CSF links destructive inflammation and comorbidities in obstructive lung disease","volume":"128","author":"Tsantikos","year":"2018","journal-title":"J Clin Invest"},{"key":"2026012204072439600_bib24","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1152\/japplphysiol.01100.2009","article-title":"Assessment of air space size characteristics by intercept (chord) measurement: an accurate and efficient stereological approach","volume":"108","author":"Knudsen","year":"2010","journal-title":"J Appl Physiol (1985)"},{"key":"2026012204072439600_bib25","doi-asserted-by":"crossref","first-page":"946","DOI":"10.4049\/jimmunol.1200660","article-title":"Distinct macrophage subpopulations characterize acute infection and chronic inflammatory lung disease","volume":"189","author":"Duan","year":"2012","journal-title":"J Immunol"},{"key":"2026012204072439600_bib26","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/iid3.430","article-title":"Granulocyte colony-stimulating factor is not pathogenic in lupus nephritis","volume":"9","author":"Gottschalk","year":"2021","journal-title":"Immun Inflamm Dis"},{"key":"2026012204072439600_bib27","doi-asserted-by":"crossref","first-page":"10729","DOI":"10.1158\/0008-5472.CAN-06-2224","article-title":"Up-regulation of expression of the ubiquitin carboxyl-terminal hydrolase L1 gene in human airway epithelium of cigarette smokers","volume":"66","author":"Carolan","year":"2006","journal-title":"Cancer Res"},{"key":"2026012204072439600_bib28","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1378\/chest.08-0820","article-title":"Pulmonary vascular involvement in COPD","volume":"134","author":"Peinado","year":"2008","journal-title":"Chest"},{"key":"2026012204072439600_bib29","first-page":"187","article-title":"Pathogenesis of hyperinflation in chronic obstructive pulmonary disease","volume":"9","author":"Gagnon","year":"2014","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2026012204072439600_bib30","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1411532","article-title":"Lung-function trajectories leading to chronic obstructive pulmonary disease","volume":"373","author":"Lange","year":"2015","journal-title":"N Engl J Med"},{"key":"2026012204072439600_bib31","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1183\/09031936.00144208","article-title":"COPD prevalence is increased in lung cancer, independent of age, sex and smoking history","volume":"34","author":"Young","year":"2009","journal-title":"Eur Respir J"},{"key":"2026012204072439600_bib32","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/08977190600581327","article-title":"The duplicitous nature of the Lyn tyrosine kinase in growth factor signaling","volume":"24","author":"Hibbs","year":"2006","journal-title":"Growth Factors"},{"key":"2026012204072439600_bib33","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1476-4598-12-76","article-title":"Lyn, a Src family kinase, regulates activation of epidermal growth factor receptors in lung adenocarcinoma cells","volume":"12","author":"Sutton","year":"2013","journal-title":"Mol Cancer"},{"key":"2026012204072439600_bib34","first-page":"48","article-title":"Epidermal growth factor receptor (EGFR) in lung cancer: an overview and update","volume":"2","author":"Bethune","year":"2010","journal-title":"J Thorac Dis"},{"key":"2026012204072439600_bib35","doi-asserted-by":"crossref","first-page":"13306","DOI":"10.1073\/pnas.0405220101","article-title":"EGF receptor gene mutations are common in lung cancers from \u201cnever smokers\u201d and are associated with sensitivity of tumors to gefitinib and erlotinib","volume":"101","author":"Pao","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026012204072439600_bib36","first-page":"154","article-title":"Epithelial mesenchymal transition and lung cancer","volume":"2","author":"Xiao","year":"2010","journal-title":"J Thorac Dis"},{"key":"2026012204072439600_bib37","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1136\/thoraxjnl-2013-204608","article-title":"Epithelial-mesenchymal transition in lung development and disease: does it exist and is it important?","volume":"69","author":"Bartis","year":"2014","journal-title":"Thorax"},{"key":"2026012204072439600_bib38","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1158\/0008-5472.CAN-09-3141","article-title":"LYN is a mediator of epithelial-mesenchymal transition and a target of dasatinib in breast cancer","volume":"70","author":"Choi","year":"2010","journal-title":"Cancer Res"},{"key":"2026012204072439600_bib39","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s12931-019-1166-z","article-title":"Lyn regulates epithelial-mesenchymal transition in CS-exposed model through Smad2\/3 signaling","volume":"20","author":"Liang","year":"2019","journal-title":"Respir Res"},{"key":"2026012204072439600_bib40","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1165\/rcmb.2021-0555OC","article-title":"Anomalous epithelial variations and ectopic inflammatory response in chronic obstructive pulmonary disease","volume":"67","author":"Watanabe","year":"2022","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026012204072439600_bib41","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3390\/cancers9050052","article-title":"Epidermal growth factor receptor cell proliferation signaling pathways","volume":"9","author":"Wee","year":"2017","journal-title":"Cancers (Basel)"},{"key":"2026012204072439600_bib42","doi-asserted-by":"crossref","first-page":"110608","DOI":"10.1016\/j.cellsig.2023.110608","article-title":"EGFR and Lyn inhibition augments regorafenib induced cell death in sorafenib resistant 3D tumor spheroid model","volume":"105","author":"Sar\u0131yar","year":"2023","journal-title":"Cell Signal"},{"key":"2026012204072439600_bib43","doi-asserted-by":"crossref","first-page":"4140","DOI":"10.1182\/blood-2013-03-491423","article-title":"A critical role for Lyn kinase in strengthening endothelial integrity and barrier function","volume":"122","author":"Han","year":"2013","journal-title":"Blood"},{"key":"2026012204072439600_bib44","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.chest.2021.01.084","article-title":"Pulmonary arterial pruning and longitudinal change in percent emphysema and lung function: the Genetic Epidemiology of COPD Study","volume":"160","author":"Pistenmaa","year":"2021","journal-title":"Chest"},{"key":"2026012204072439600_bib45","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00441-016-2545-0","article-title":"Development of the lung","volume":"367","author":"Schittny","year":"2017","journal-title":"Cell Tissue Res"},{"key":"2026012204072439600_bib46","doi-asserted-by":"crossref","first-page":"L134","DOI":"10.1152\/ajplung.00050.2004","article-title":"VEGF causes pulmonary hemorrhage, hemosiderosis, and air space enlargement in neonatal mice","volume":"287","author":"Le Cras","year":"2004","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2026012204072439600_bib47","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s12011-016-0818-9","article-title":"Selenium alleviates oxidative stress and lung damage induced by aluminum chloride in adult rats: biochemical and histological approach","volume":"176","author":"Ghorbel","year":"2017","journal-title":"Biol Trace Elem Res"},{"key":"2026012204072439600_bib48","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12890-017-0408-4","article-title":"Hemosiderin in sputum macrophages may predict infective exacerbations of chronic obstructive pulmonary disease: a retrospective observational study","volume":"17","author":"Mohan","year":"2017","journal-title":"BMC Pulm Med"},{"key":"2026012204072439600_bib49","first-page":"4595019","article-title":"Hemosiderin-laden macrophages in bronchoalveolar lavage: predictive role for acute exacerbation of idiopathic interstitial pneumonias","volume":"2021","author":"Arai","year":"2021","journal-title":"Can Respir J"},{"key":"2026012204072439600_bib50","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1177\/1753465813479428","article-title":"Early life influences on the development of chronic obstructive pulmonary disease","volume":"7","author":"Stocks","year":"2013","journal-title":"Ther Adv Respir Dis"},{"key":"2026012204072439600_bib51","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1164\/rccm.201912-2338OC","article-title":"Lung development genes and adult lung function","volume":"202","author":"Portas","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012204072439600_bib52","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S2213-2600(18)30100-0","article-title":"Childhood predictors of lung function trajectories and future COPD risk: a prospective cohort study from the first to the sixth decade of life","volume":"6","author":"Bui","year":"2018","journal-title":"Lancet Respir Med"},{"key":"2026012204072439600_bib53","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1001\/archinte.163.12.1475","article-title":"Low lung function and incident lung cancer in the United States: data From the First National Health and Nutrition Examination Survey follow-up","volume":"163","author":"Mannino","year":"2003","journal-title":"Arch Intern Med"},{"key":"2026012204072439600_bib54","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ebiom.2019.08.058","article-title":"Determinants of impaired lung function and lung cancer prediction among never-smokers in the UK Biobank cohort","volume":"47","author":"Warkentin","year":"2019","journal-title":"EBioMedicine"},{"key":"2026012204072439600_bib55","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.4049\/jimmunol.175.3.1867","article-title":"Lyn-deficient mice develop severe, persistent asthma: Lyn is a critical negative regulator of Th2 immunity","volume":"175","author":"Beavitt","year":"2005","journal-title":"J Immunol"},{"key":"2026012204072439600_bib56","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3389\/fped.2019.00246","article-title":"Epidemiology of asthma in children and adults","volume":"7","author":"Dharmage","year":"2019","journal-title":"Front Pediatr"},{"key":"2026012204072439600_bib57","doi-asserted-by":"crossref","first-page":"5490","DOI":"10.1172\/JCI72573","article-title":"LYN-activating mutations mediate antiestrogen resistance in estrogen receptor-positive breast cancer","volume":"124","author":"Schwarz","year":"2014","journal-title":"J Clin Invest"},{"key":"2026012204072439600_bib58","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/art.42354","article-title":"De novo gain-of-function variations in LYN associated with an early-onset systemic autoinflammatory disorder","volume":"75","author":"Louvrier","year":"2023","journal-title":"Arthritis Rheumatol"}],"container-title":["American Journal of Respiratory Cell and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrcmb\/article-pdf\/69\/1\/99\/66300584\/ajrcmb_69_1_99.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrcmb\/article-pdf\/69\/1\/99\/66300584\/ajrcmb_69_1_99.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T09:13:22Z","timestamp":1769073202000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrcmb\/article\/69\/1\/99\/8416852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,1]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,7,1]]},"published-print":{"date-parts":[[2023,7,1]]}},"URL":"https:\/\/doi.org\/10.1165\/rcmb.2022-0463oc","relation":{},"ISSN":["1044-1549","1535-4989"],"issn-type":[{"value":"1044-1549","type":"print"},{"value":"1535-4989","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,7]]},"published":{"date-parts":[[2023,7,1]]},"assertion":[{"value":"2022-12-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}